» Articles » PMID: 31734198

Interplay of Coronary Artery Calcium And Risk Factors for Predicting CVD/CHD Mortality: The CAC Consortium

Abstract

Objectives: This study sought to evaluate the association and burden of coronary artery calcium (CAC) with long-term, cause-specific mortality across the spectrum of baseline risk.

Background: Although CAC is a known predictor of short-term, all-cause mortality, data on long-term and cause-specific mortality are inadequate.

Methods: The CAC Consortium cohort is a multicenter cohort of 66,636 participants without coronary heart disease (CHD) who underwent CAC testing. The following risk factors (RFs) were considered: 1) current cigarette smoking; 2) dyslipidemia; 3) diabetes mellitus; 4) hypertension; and 5) family history of CHD.

Results: During the 12.5-years median follow-up, 3,158 (4.7%) deaths occurred; 32% were cardiovascular disease (CVD) deaths. Participants with CAC scores ≥400 had a significantly increased risk for CHD and CVD mortality (hazard ratio [HR]: 5.44; 95% confidence interval [CI]: 3.88 to 7.62; and HR: 4.15; 95% CI: 3.29 to 5.22, respectively) compared with CAC of 0. Participants with ≥3 RFs had a smaller increased risk for CHD and CVD mortality (HR: 2.09; 95% CI: 1.52 to 2.85; and HR: 1.84; 95% CI: 1.46 to 2.31, respectively) compared with those without RFs. Across RF strata, CAC added prognostic information. For example, participants without RFs but with CAC ≥400 had significantly higher all-cause, non-CVD, CVD, and CHD mortality rates compared with participants with ≥3 RFs and CAC of 0.

Conclusions: Across the spectrum of RF burden, a higher CAC score was strongly associated with long-term, all-cause mortality and a greater proportion of deaths due to CVD and CHD. Absence of CAC identified people with a low risk over 12 years of follow-up, with most deaths being non-CVD in nature, regardless of RF burden.

Citing Articles

Is Preventative Oophorectomy Safe?: Providing Reassurance to Young Women at Risk.

Tesch M, Drachman D, Mayer E JACC CardioOncol. 2025; 6(6):932-934.

PMID: 39801652 PMC: 11711828. DOI: 10.1016/j.jaccao.2024.11.001.


Current Status of Cardiac CT for Nuclear Medicine Professionals: Coronary Artery Disease Evaluation.

Ko S Nucl Med Mol Imaging. 2024; 58(7):418-430.

PMID: 39635633 PMC: 11612094. DOI: 10.1007/s13139-024-00859-0.


Beyond the Agatston calcium score: role of calcium density and other calcified plaque markers for cardiovascular disease prediction.

Razavi A, Whelton S, Blumenthal R, Blaha M, Dzaye O Curr Opin Cardiol. 2024; 40(1):56-62.

PMID: 39445716 PMC: 11620923. DOI: 10.1097/HCO.0000000000001185.


Preventing ASCVD Events: Using Coronary Artery Calcification Scores to Personalize Risk and Guide Statin Therapy.

Kupfer J, Silvet H, Aguayo S Fed Pract. 2024; 41(5):142-148.

PMID: 39398965 PMC: 11468628. DOI: 10.12788/fp.0433.


Cardiovascular Aging and Risk Assessment: How Multimodality Imaging Can Help.

Hrabak Paar M, Mursic M, Bremerich J, Heye T Diagnostics (Basel). 2024; 14(17).

PMID: 39272731 PMC: 11393882. DOI: 10.3390/diagnostics14171947.